Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suli Jiang

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
International Immunopharmacology|May 29, 2023
The role of CXCL1/CXCR2 axis in neurological diseasesSuli Jiang, Jie Liang, Wei Li, et al.
International Immunopharmacology|August 18, 2022
Research progress of targeting NLRP3 inflammasome in peripheral nerve injury and painWei Li, Jie Liang, Shaohua Li, et al.
International Immunopharmacology|February 13, 2024
Pathogenic Th17 cell-mediated liver fibrosis contributes to resistance to PD-L1 antibody immunotherapy in hepatocellular carcinomaMeiying Song, Luoyang Wang, Suli Jiang, et al.
International Immunopharmacology|August 14, 2023
IL-17A functions and the therapeutic use of IL-17A and IL-17RA targeted antibodies for cancer treatmentMeiying Song, Jie Liang, Luoyang Wang, et al.
International Immunopharmacology|June 29, 2024
The protective effect of erythropoietin and its novel derived peptides in peripheral nerve injuryGuixian Liu, Jie Liang, Wei Li, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
International Immunopharmacology|May 29, 2023
The role of CXCL1/CXCR2 axis in neurological diseasesSuli Jiang, Jie Liang, Wei Li, et al.
International Immunopharmacology|August 18, 2022
Research progress of targeting NLRP3 inflammasome in peripheral nerve injury and painWei Li, Jie Liang, Shaohua Li, et al.
International Immunopharmacology|February 13, 2024
Pathogenic Th17 cell-mediated liver fibrosis contributes to resistance to PD-L1 antibody immunotherapy in hepatocellular carcinomaMeiying Song, Luoyang Wang, Suli Jiang, et al.
International Immunopharmacology|August 14, 2023
IL-17A functions and the therapeutic use of IL-17A and IL-17RA targeted antibodies for cancer treatmentMeiying Song, Jie Liang, Luoyang Wang, et al.
International Immunopharmacology|June 29, 2024
The protective effect of erythropoietin and its novel derived peptides in peripheral nerve injuryGuixian Liu, Jie Liang, Wei Li, et al.
Pageof 2